Skip to main content
FinSpry Logo
FinSpry
TXMD logo
TXMD
(NASDAQ)
TherapeuticsMD, Inc.
$2.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

TherapeuticsMD (TXMD) Stock Price & Financial Analysis

TherapeuticsMD Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.94 - $2.05
52-Week High$2.95
52-Week Low$0.84
Open$2.00
Volume16.09K
Average Volume (3M)16.09K
Market Cap23.15M
Shares Outstanding11.57M
P/E Ratio (TTM)76.65
Price to Sales (P/S)8.28
Price to Book (P/B)0.84
EV/EBITDA-29.90
Revenue (TTM)2.80M
Net Income (TTM)302.00K
EPS (TTM)$0.03
Profit Margin10.80%
Operating Margin-93.71%
Return on Equity (ROE)1.10%
Debt to Equity0.24
50-Day MA$2.28
200-Day MA$1.57
52-Week Change104.08%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateJun 10, 2008

Frequently Asked Questions About TherapeuticsMD

What is the current stock price for TXMD?

As of the latest trading session, TXMD stock trades at $2.00. The 52-week range is $0.84–$2.95, with a day range of $1.94–$2.05.

What is the P/E ratio for TXMD?

TherapeuticsMD's trailing P/E ratio is 76.7, meaning investors pay $76.7 for every $1 of annual earnings. TherapeuticsMD operates in the Healthcare sector.

Does TXMD pay dividends?

TherapeuticsMD does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TXMD?

Analyst ratings and recommendations for TXMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of TXMD?

TherapeuticsMD's market capitalization is $23.1M, classifying it as a micro-cap company. TherapeuticsMD operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.